Percutaneous Coronary Revascularization clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Evaluation in STEMI Patients Using FDY-5301

    open to eligible people ages 18 years and up

    To assess the effect of FDY-5301 on cardiovascular mortality and acute heart failure events in subjects with an anterior STEMI undergoing pPCI.

    at UCLA

Last updated: